MoneyWorks4Me

Granules India informs about disclosure

23 Nov 2023 Evaluate
Pursuant to Regulation 30(6) read with Para A of Part A of Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, (Listing Regulations), Granules India has informed that the Company has received a communication from the GST authorities directing for payment of tax liability for the tax period July 2017 to March 2021 pursuant to the filings made by the Company. The details as required under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. SEBI/HO/CFD/CFD-PoD1/P/CIR/2023/123 dated 13 July 2023, is enclosed as an Annexure -A.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1854.05
Dr. Reddys Labs. 1195.45
Cipla 1378.35
Lupin 2093.00
Zydus Lifesciences 1158.25
View more..